Translate:
Sign Up
TwitterFacebookLinkedin
Search
  • Dr. Brian Koffman’s Blog
More Links
CLL SocietyCLL Society
CLL Society
Patients and providers fighting CLL together
Smart Patients Get Smart Care™
Donate to CLL Society
  • Home
  • Basics
    • Basic Terms
    • Getting Started
    • Test Before Treat™
    • Early Care
    • Treatment
    • Cake of Cure for CLL
    • CLL Comic Book
    • CLL FAQs
  • Beyond The Basics
    • CLL Overview by Dr. Kipps
    • Richter’s Transformation
    • CAR-T and Other Cellular Therapies
    • Treatment
    • What About CT Scans?
    • How is Treatment Selected?
    • Advanced Prognostics
  • Living Well With CLL
    • Paid Market Research Opportunities
    • Impact of Diagnosis
    • Taking Charge
    • Becoming Informed
    • Support
    • Caregivers
    • Planning Ahead
  • Clinical Trials
    • The Basics
    • The Patient Perspective
    • News about Clinical Trials
  • Conference Coverage
    • 2019 Conferences
    • 2018 Conferences
    • Past Years
      • 2017 Conferences
      • 2016 Conferences
      • 2015 Conferences
      • 2014 Conferences
      • 2013 Conferences
    • Links To Blog Conference Coverage
  • CAR-T
  • Support Groups/Education
    • CLL Society Patient & Caregiver Educational Forums
    • The CLL Bloodline
    • Support Group Calendar
    • Support Group Contact
    • Leader Resources
    • CLL-Specific Patient Support Groups
    • Upcoming CLL Patient Education Programs
    • Archived Educational Activities
  • News
    • CLL Society in the News
    • The CLL Society Tribune
      • Ask & Tell
      • Ask The Doctor
      • Ask The Pharmacist
      • Did You Know?
    • Business, Finances, Insurance & Regulatory
    • Official Statements and Press Releases
    • Clinical
    • CLL Society Alerts
  • About Us
    • Contact
    • Mission & Vision
    • Board of Directors
    • Medical Advisory Board
    • Patient Advisory Board
    • The CLL Society Staff
    • The Orange County CLL Support Group
    • Volunteer With Us!
Menu back  

Category Archives: News about Clinical Trials

You are here:
  1. Home
  2. Clinical Trials
  3. Category "News about Clinical Trials"

CAR-T Trial for JCAR017 Now Open at USCD and 27 Other Sites Across the USA

An Open-Label, Phase 1/2 Study of JCAR017 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma...
October 5, 2019News about Clinical TrialsBy Brad Hedrick

The Transcend 004 Clinical Trial

The Transcend CLL 004 Clinical Trial is looking for patients with relapsed or refractory CLL/SLL. The investigational treatment uses a...
July 15, 2019News about Clinical TrialsBy Brad Hedrick

A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated CLL

A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated CLL offers an option of a novel agent...
July 9, 2019News about Clinical TrialsBy Brad Hedrick

Two New Free Vaccine Trials at the NIH

The National Institutes of Health were founded by Congress in 1887 and charged with being the preeminent research center in...
April 9, 2019News about Clinical TrialsBy Brad Hedrick

Clinical Trials and our Clinical Trial Banner

You may notice a new feature on the CLL Society website, a Clinical Trial Banner on our home page. As many...
October 21, 2018News about Clinical TrialsBy Brad Hedrick

New trial for early stage high-risk CLL patients.

The vast majority of patients (approximately 75%) with newly diagnosed CLL do not need treatment at the time of initial...
October 12, 2018News about Clinical TrialsBy Brad Hedrick

Monoclonal B-cell Lymphocytosis Study

Researchers at Queen’s University Belfast in the UK, are conducting the first large-scale survey of Monoclonal B-cell lymphocytosis patients and...
March 16, 2018News about Clinical TrialsBy Todd Dennison

CAR-T trial for CLL (chronic lymphocytic leukemia) at City of Hope

City of Hope is one of the leading centers for novel cellular therapies. Slots for a Juno CAR-T CLL trial...
February 21, 2018News about Clinical TrialsBy Todd Dennison

A Clinical Trial for Chronic Lymphocytic Leukemia (CLL) Patients Intolerant of Prior Therapies

While novel kinase inhibitor (KI) medications such as ibrutinib and idelalisib have revolutionized care for chronic lymphocytic leukemia (CLL), some...
July 11, 2017News about Clinical TrialsBy Todd Dennison

A New Clinical Trial for Patients with Relapsed Refractory CLL Who Have Received 2 or more Prior Treatments, Including Treatment with a BTK Inhibitor such as Ibrutinib or Acalabrutinib

PURPOSE OF THE STUDY: The purpose of the study is to test the investigational oral drug known as SNS-062, a...
June 13, 2017News about Clinical TrialsBy Todd Dennison
12
Next page
  • Home
  • Basics
    • Basic Terms
    • Getting Started
    • Test Before Treat™
    • Early Care
    • Treatment
    • Cake of Cure for CLL
    • CLL Comic Book
    • CLL FAQs
  • Beyond The Basics
    • CLL Overview by Dr. Kipps
    • Richter’s Transformation
    • CAR-T and Other Cellular Therapies
    • Treatment
    • What About CT Scans?
    • How is Treatment Selected?
    • Advanced Prognostics
  • Living Well With CLL
    • Paid Market Research Opportunities
    • Impact of Diagnosis
    • Taking Charge
    • Becoming Informed
    • Support
    • Caregivers
    • Planning Ahead
  • Clinical Trials
    • The Basics
    • The Patient Perspective
    • News about Clinical Trials
  • Conference Coverage
    • 2019 Conferences
    • 2018 Conferences
    • Past Years
      • 2017 Conferences
      • 2016 Conferences
      • 2015 Conferences
      • 2014 Conferences
      • 2013 Conferences
    • Links To Blog Conference Coverage
  • CAR-T
  • Support Groups/Education
    • CLL Society Patient & Caregiver Educational Forums
    • The CLL Bloodline
    • Support Group Calendar
    • Support Group Contact
    • Leader Resources
    • CLL-Specific Patient Support Groups
    • Upcoming CLL Patient Education Programs
    • Archived Educational Activities
  • News
    • CLL Society in the News
    • The CLL Society Tribune
      • Ask & Tell
      • Ask The Doctor
      • Ask The Pharmacist
      • Did You Know?
    • Business, Finances, Insurance & Regulatory
    • Official Statements and Press Releases
    • Clinical
    • CLL Society Alerts
  • About Us
    • Contact
    • Mission & Vision
    • Board of Directors
    • Medical Advisory Board
    • Patient Advisory Board
    • The CLL Society Staff
    • The Orange County CLL Support Group
    • Volunteer With Us!
Navigation
We’d like to thank our supporters:
  • AbbVie
  • AstraZeneca
  • Beigene
  • Celgene
  • Genentech/Biogen Idec
  • Gilead
  • Juno
  • Pharmacyclics/Janssen
  • Sunesis Pharmaceuticals
  • TG Therapeutics
  • Verastem
Copyright 2019 CLL Society, Inc. All Rights Reserved.
Terms & Conditions | Privacy Policy





Social media & sharing icons powered by UltimatelySocial
This site uses cookies: Find out more.